Oral Hsp90 Inhibitor, SNX-5422, Attenuates SARS-CoV-2 Replication and Dampens Inflammation in Airway Cells | Zendy

AI Assistant Blog Pricing

Open Access

Oral Hsp90 Inhibitor, SNX-5422, Attenuates SARS-CoV-2 Replication and Dampens Inflammation in Airway Cells

Author(s) -

Ria Goswami,

Veronica Russell,

Joshua J. Tu,

Philip F. Hughes,

Francine L. Kelly,

Stephanie N. Langel,

Justin T. Steppe,

Scott M. Palmer,

Timothy Haystead,

Maria Blasi,

Sallie R. Permar

Publication year - 2021

Publication title -

ssrn electronic journal

Language(s) - English

Resource type - Journals

ISSN - 1556-5068

DOI - 10.2139/ssrn.3803615

Subject(s) - inflammation , medicine , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.